The Max Planck Institute in Leipzig acquires second Genome Sequencing FLX™ System
454 Life Sciences, a part of Roche Applied Science, today announced that the Max Planck Institute for Evolutionary Anthr…
454 Life Sciences, a part of Roche Applied Science, today announced that the Max Planck Institute for Evolutionary Anthr…
Roche and ACEA Biosciences Inc., San Diego, USA today announced that they have entered into an exclusive agreement for t…
Roche and Eppendorf, both companies offering systems for use in life-science research, announced that they have entered…
454 Life Sciences, a Roche company, and Perlegen Sciences, Inc., today announced a collaboration to conduct large scale…
454 Life Sciences, a Roche company, is the subject of three ground-breaking studies published this week in Science, all…
454 Life Sciences, a Roche company, in collaboration with researchers from the University of Illinois at Urbana-Champaig…
For over a decade, FuGENE® Transfection Reagents have been associated with leading research labs the world over, making…
Roche NimbleGen Inc., a fully integrated part of Roche Applied Science today announced the addition of 4-plex eukaryotic…
454 Life Sciences, a Roche company, today announced that researchers at Columbia University, in collaboration with 454,…
454 Life Sciences, the sequencing center of excellence of Roche Applied Science today announced the launch of new produc…